Application 020715
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TRELSTAR | TRIPTORELIN PAMOATE | INJECTABLE;INTRAMUSCULAR | EQ 3.75MG BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020715-001 | TRELSTAR | TRIPTORELIN PAMOATE | EQ 3.75MG BASE/VIAL | INJECTABLE / INTRAMUSCULAR | RLD, RS | 2000-06-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020715-001 | TRELSTAR | EQ 3.75MG BASE/VIAL | INJECTABLE / INTRAMUSCULAR | RLD, RS | 2000-06-15 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020715-001 | TRELSTAR | EQ 3.75MG BASE/VIAL | INJECTABLE / INTRAMUSCULAR | RLD, RS | 2000-06-15 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020715-001 | TRELSTAR | EQ 3.75MG BASE/VIAL | INJECTABLE / INTRAMUSCULAR | RLD, RS | 2000-06-15 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020715-001 | TRELSTAR | EQ 3.75MG BASE/VIAL | INJECTABLE / INTRAMUSCULAR | RLD, RS | 2000-06-15 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trelstar | TRIPTORELIN PAMOATE | Verity Pharmaceuticals Inc. | b1b84d62-a369-a4b7-5c41-dd1f553a18f3 | 2026-06-30 | Warnings, Adverse reactions | 020715 NDA020715 74676-5902 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0023-5902 | Trelstar | triptorelin pamoate | Allergan, Inc. | NDA | Current |
| 0023-5902 | Trelstar | triptorelin pamoate | Allergan, Inc. | NDA | Current |
| 74676-5902 | Trelstar | triptorelin pamoate | Verity Pharmaceuticals Inc. | NDA | Current |
| 74676-5902 | Trelstar | triptorelin pamoate | Verity Pharmaceuticals Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83477 | SUPPL | 2025-09-25 |
| 83432 | SUPPL | 2025-09-25 |
| 81570 | SUPPL | 2025-03-14 |
| 81550 | SUPPL | 2025-03-13 |
| 78142 | SUPPL | 2024-04-15 |
| 78129 | SUPPL | 2024-04-15 |
| 76639 | SUPPL | 2023-11-21 |
| 76633 | SUPPL | 2023-11-20 |
| 73689 | SUPPL | 2023-03-06 |
| 73685 | SUPPL | 2023-03-06 |
| 56908 | SUPPL | 2018-12-21 |
| 56782 | SUPPL | 2018-12-18 |
| 25621 | SUPPL | 2014-07-15 |
| 13279 | SUPPL | 2014-07-15 |
| 25620 | SUPPL | 2013-03-15 |
| 13278 | SUPPL | 2013-03-15 |
| 23595 | ORIG | 2011-12-20 |
| 25619 | SUPPL | 2011-05-24 |
| 35210 | SUPPL | 2011-05-23 |
| 35209 | SUPPL | 2011-01-20 |
| 3184 | SUPPL | 2011-01-20 |
| 3183 | SUPPL | 2008-04-16 |
| 25618 | SUPPL | 2005-10-25 |
| 20873 | ORIG | 2002-07-31 |
| 25617 | SUPPL | 2002-01-15 |
| 3182 | SUPPL | 2002-01-15 |
| 35208 | ORIG | 2000-06-15 |
| 25616 | ORIG | 2000-06-15 |